Cash from Investing (Quarterly) Chart

View Cash from Investing (Quarterly) for FMS.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Cash from Investing (Quarterly) Chart
Start Trial

Historical Cash from Investing (Quarterly) Data

View and export this data back to 2001. Start Trial.
Date Value
June 30, 2026 -312.01M
March 31, 2026 -191.50M
December 31, 2025 -465.64M
September 30, 2025 -61.77M
June 30, 2025 -149.34M
March 31, 2025 -108.97M
December 31, 2024 -121.14M
September 30, 2024 -234.38M
June 30, 2024 355.53M
March 31, 2024 -68.80M
December 31, 2023 -83.05M
September 30, 2023 -156.67M
June 30, 2023 -125.04M
March 31, 2023 -173.00M
December 31, 2022 -195.96M
September 30, 2022 -78.04M
June 30, 2022 -173.26M
March 31, 2022 -225.95M
December 31, 2021 -472.04M
September 30, 2021 -340.23M
June 30, 2021 -280.31M
March 31, 2021 -259.51M
December 31, 2020 -513.40M
September 30, 2020 -318.43M
June 30, 2020 -293.81M
Date Value
March 31, 2020 -339.75M
December 31, 2019 -510.86M
September 30, 2019 -405.47M
June 30, 2019 -389.67M
March 31, 2019 -2.275B
December 31, 2018 -604.82M
September 30, 2018 -687.07M
June 30, 2018 1.564B
March 31, 2018 -482.33M
December 31, 2017 20.03M
September 30, 2017 -329.58M
June 30, 2017 -384.29M
March 31, 2017 -368.51M
December 31, 2016 -451.05M
September 30, 2016 -195.43M
June 30, 2016 -321.85M
March 31, 2016 -337.10M
December 31, 2015 -241.32M
September 30, 2015 -281.77M
June 30, 2015 -268.76M
March 31, 2015 -208.84M
December 31, 2014 -976.25M
September 30, 2014 -827.38M
June 30, 2014 -516.72M
March 31, 2014 -339.68M

Cash From Investing Definition

Represents the net cash flow from the company's investing activities. Investing activities represent the movement in the company's long-term assets.

Read full definition.

Cash from Investing (Quarterly) Range, Past 5 Years

View Cash from Investing (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Cash from Investing (Quarterly) Benchmarks

View Cash from Investing (Quarterly) Benchmarks
Start Trial
DaVita, Inc. -194.55M
Rhön-Klinikum AG --
FamiCord AG -0.774M
Quest Diagnostics, Inc. -134.00M
Acadia Healthcare Co., Inc. -32.68M